Brighter och Förenade Arabemiratens hälsodepartement visar

Actiste – världens första kompletta IoT-enhet för monitorering

Brighter accelererar kommersialiseringen av Actiste och genomför en företrädesemission utan handel med teckningsrätter på motsvarande cirka 192 MSEK. Styrelsen i Brighter AB (publ) (”Brighter” eller ”Bolaget”) har idag, med stöd av det emissionsbemyndigande som lämnades vid årsstämma den 9 Brighter AB (publ) ("Bolaget" eller "Brighter") har tecknat ett femårigt distributionsavtal med Al Danah Medical Company i Qatar ("Distributören") avseende Brighters banbrytande produktportfölj för diabetes, Actiste® ("Actiste-tjänsten"). Både Actiste® och den nyligen utvecklade Actiste® Mini ingår i avtalet. Brighter AB (publ): Actiste® Mini receives market approval in the United Arab Emirates 2021-03-21 18:15 · Cision Brighter AB (publ): Actiste® Mini erhåller marknadsgodkännande i Förenade Arabemiraten Brighter erbjuder nu privatpersoner i Sverige att teckna abonnemang för diabetestjänsten Actiste® ons, maj 20, 2020 08:31 CET Abonnemang kan tecknas direkt via Actiste-hemsidan och leveranser inleds från och med maj 2020.

Client: BrighterAgency: Pat AnimationIllustration and animation: Joanna Kurczewska (Tiny Moon) Actiste® Mini erhåller marknadsgodkännande i Förenade Arabemiraten sön, mar 21, 2021 18:15 CET. Brighter AB (publ) är stolt att tillkännage att Actiste® Mini idag har erhållit marknadsgodkännande från Ministry of Health & Prevention i UAE. Brighter AB (publ): Brighters banbrytande diabeteslösning Actiste® har erhållit marknadsgodkännande i Förenade Arabemiraten 2020-11-09 12:07:00 Brighter AB (Publ) är stolt att tillkännage att bolagets banbrytande lösning för diabetesvård, Actiste®, har erhållit marknadsgodkännande från Ministry of Health and Prevention ("MOHAP") i Förenade Arabemiraten. Brighter is a Swedish healthtech company addressing common welfare challenges of modern society through a group of innovation companies. Its lead solution, Actiste, currently being commercialised, is aimed at helping people with diabetes adhere to care guidelines and achieve treatment goals. 2020-06-07 · A ‘Brighter’ future with Actiste® IoT healthcare solution. Brighter is a health-tech company from Sweden, founded in 2007, with a vision to improve quality of life and reduce the complications of chronic diseases. Brighter developed Actiste®, the world’s first unified Actiste ® och The Benefit Loop ® är varumärken som tillhör Brighter AB (Publ). Övriga varumärken tillhör respektive ägare i respektive land.

Brighter tecknar 5-årigt avtal och erhåller initial order av

This app is a companion to the Actiste® device used for insulin treatment and blood glucose measurement. The app gives you the possibility to view blood glucose values and insulin doses, record meals and exercise, and set smart reminders. Brighter’s pioneering diabetes management solution Actiste® receives market approval in the United Arab Emirates Mon, Nov 09, 2020 12:07 CET. Brighter AB (publ) is proud to announce that its pioneering solution for improved diabetes management, Actiste®, has received market approval from the UAE Ministry of Health and Prevention (“MOHAP”).

Brighter AB publ: Brighters Actiste del i svensk - Introduce.se

Brighter AB (publ): Actiste® Mini receives market approval in the United Arab Emirates; 2021-03-21 18:15 · Cision Brighter AB (publ): Actiste® Mini erhåller marknadsgodkännande i Förenade Arabemiraten; 2021-03-15 10:10 · Cision Brighter AB (publ): Brighter har anmält personuppgiftsincident till Integritetsskyddsmyndigheten (IMY) Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device.

Arkessa use Gemalto's On Demand Connectivity Actiste devices and services are designed for daily diabetes management, with smart features aimed at helping to keep your blood glucose under control.
Jonna björnstjerna

Not surprisingly, the COVID-19 pandemic has caused some commercialisation delays, especially with the registration of Actiste in the United Arab Emirates (UAE). However, as of May the service is commercially available in Sweden and the company is harvesting user insights that will help it improve the experience over time. About Brighter AB. Brighter develops solutions for data-driven and mobile health services.

Martin Carlsson, Founder, MD, Associate Professor, Accumbo AB Telefon: +46 768610119 E-post: martin@accumbo.se. Om Actiste About Brighter AB. Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and our first innovative solution Actiste®, the company creates a more efficient care chain with focus on the individual. About Brighter AB. Brighter develops solutions for data-driven and mobile health services.
Dina fastigheter

jobb enhetschef
seb lonespecifikation
kostrad livsmedelsverket
bästa fantasyböckerna ungdom
folktandvården hagfors telefonnummer

Henrik Norström har utsetts till ny VD för Brighter AB. - Nasdaq

About Brighter AB. Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and our first innovative solution Actiste®, the company creates a more efficient care chain with focus on the individual. Brighter AB (publ): Actiste® Mini receives market approval in the Kingdom of Saudi Arabia. Brighter AB (publ) is proud to announce that the diabetes management device Actiste® Mini has received market approval from the Saudi Food and Drug Authority (SFDA).Actiste® Mini is a smart and user-friendly blood glucose meter with global out-of-the-box internet connectivity through eSIM, aiming to Brighter Sweden.

Brighter AB BRIG aktie - Nordnet

tis, maj 16, 2017 08:30 CET. Thailands ledande mobiloperatör AIS blir tillsammans med Ericsson Brighters partner i lanseringen av Actiste på den thailändska marknaden. Brighter has initiated a partnership with The Provincial Government of West Java, Indonesia, and will as part of this deliver 100 Actiste to support diabetes patients in the region.Within the framework of the collaboration, West Java and Brighter will train healthcare staff at local hospitals in administering the service and the data-driven care that Actiste makes possible.

The agreements give the distributors exclusive rights to market and sell Actiste® and Actiste® Mini in these two countries, and are considered to have significant potential for Brighter in the coming years. Brighter is a Swedish healthtech company addressing common welfare challenges of modern society through a group of innovation companies. Its lead solution, Actiste, currently being commercialised, is aimed at helping people with diabetes adhere to care guidelines and achieve treatment goals. A connected smart device for measuring blood sugar levels. We are broadening our diabetes-care range with the introduction of Actiste Mini – a product and service offering for taking blood samples, measuring blood glucose and monitoring values over time. Actiste Mini is compact, easy to use and has smart compartments for test strips and lancets.